ESC 365 - Acute heart failure drug development: challenges and learnings.

Open Access

Acute heart failure drug development: challenges and learnings.

Session: Advancing acute heart failure treatment – quo vadis?

Topic: Acute Heart Failure

Speaker: Professor J. McMurray (Glasgow, GB)

Sponsored by Novartis

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

127 presentations

26 followers

4 more presentations in this session

Welcome and introduction.

Speaker: Professor A. Mebazaa (Paris, FR) Professor J. McMurray (Glasgow, GB)

Recent and future developments in acute heart failure therapies.

Speaker: Professor J. Teerlink (San Francisco, US)

Improving outcomes in acute heart failure: quo vadis?

Speaker: Professor J. McMurray (Glasgow, GB) Professor J. Teerlink (San Francisco, US) Professor A. Mebazaa (Paris, FR)

Summary and key learnings.

Speaker: Professor J. McMurray (Glasgow, GB)

Access the full session

Advancing acute heart failure treatment – quo vadis?

Speakers: Professor J. McMurray, Professor A. Mebazaa, Professor J. McMurray, Professor J. Teerlink, Professor J. McMurray...

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources